July 11, 2023
Yet despite these promises, email correspondence obtained through FOIA requests by Demand Progress show that senior officials across USTR, including Deputy U.S. Trade Representative Sarah Bianchi, actively seek input from executives at Big Tech firms such as Amazon and Google. Giving Big Tech a privileged ability to mold American trade policy undermines Biden’s commitment to a new era of trade deals.
January 04, 2022
One tiny federal agency with 116 full-time employees and a $28.9 million dollar budget is in charge of regulating the global marine economy, which contributes $397 billion to the US GDP annually and accounts for 80 percent of goods shipped worldwide. That’s not just an apples and oranges discrepancy—that’s like an apple versus Apple. The budget for the military’s marching bands is fifteen times greater than the Federal Maritime Commission’s budget; the Marines alone have five times more musicians than the Commission has staff.
September 29, 2021 | The American Prospect
When United States Trade Representative Katherine Tai announced this past May that the U.S. would support the TRIPS waiver on COVID-19 vaccines at the World Trade Organization (WTO), we at the Revolving Door Project celebrated the administration’s decision as “a transformative, hopeful event.” The waiver proposal calls on the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to suspend intellectual-property protections on COVID-19 therapeutics, diagnostics, and vaccines to ensure materials necessary for combating the pandemic are “available promptly, in sufficient quantities and at affordable price to meet global demand.”
July 22, 2021
In 2019, Gallup found that the pharmaceutical industry was “the most poorly regarded industry in Americans’ eyes,” and rightfully so. Pharmaceutical companies often set drug prices exorbitantly high, including life-saving drugs which patients literally cannot go without, such as insulin. This includes older drugs that are cheaper to produce — such as epinephrine (emergency medication used to treat severe allergic reactions and asthma attacks). These firms achieve this by stifling competition at the consumer’s expense, jealously protecting their money-makers from the generics which the pharmaceutical system is supposed to develop after a patent expires.
April 23, 2021 | The American Prospect
The Biden administration is divided over whether to waive trade protections for Big Pharma—with Commerce Secretary Gina Raimondo as a key industry ally.
April 14, 2021
With his nomination of Katherine Tai, who has advocated for a worker-centered trade policy, Biden demonstrated his commitment to transforming the trade agenda in the Democratic party. Unfortunately, his choice of Sarah Bianchi to serve as deputy USTR could undermine these efforts:
October 23, 2020
Over the past decades, U.S. trade policies have primarily served the interests of corporate America. The result? The American worker experienced few if any of the promised benefits of globalization. President Trump seized upon this in his bid for the Presidency in 2016, but his declaration of China as an enemy and ill-advised trade war have only widened the trade deficit he vowed to close. The data show that the trade deficit reached $67 billion in August, its highest level since August 2006. More so, job growth in the manufacturing sector has been on decline since before the pandemic. Indeed, the current deficit in manufactured goods, $84 billion, is the largest on record with data starting in 1992.
June 17, 2020
Jason Bernstein and Fred Fischer, both Deputy Assistant U.S. Trade Representatives, reached out to auto industry representatives offering to “assist companies directly with their USMCA implementation needs,” according to Bloomberg’s report. The report did not confirm whether Bernstein and Fischer asked for or received clearance to contact the auto companies, while ethics experts speculate that offering such services while still employed by the government might breach federal ethics requirements.